Weekly Digest – July 2026 Weekly Digest – July 2026 10 July 2026: Hansoh Pharma announces ARTEMIS-008 trial achieved primary OS endpoint in SCLC Hansoh Pharma announced that its B7-H3-targeted antibody-drug conjugate Risvutatug rezetecan met the primary endpoint of overall […]